相关实验视频

Updated: Jun 19, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

在Redo的低温心房动中进行最少的侵入性中枢手术:为手术挑战提供一个有希望的解决方案

Jawad Salman¹, Maximilian Franz¹, Khalil Aburahma¹

¹Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30625 Hannover, Germany.

Journal of clinical medicine

|July 27, 2024

概括

低温心房动是一种安全的替代心脏保护策略,用于最小侵入性中枢门手术 (MIMVS) 重复病例,特别是在冠状动脉旁路移植 (CABG) 后. 这种方法在具有挑战性的患者群体中显示了与传统方法相似的结果.

科学领域:

心脏外科手术心脏外科手术
心脏保护策略心脏保护策略
最少侵入性的心脏手术

背景情况:

最少侵入性 mitra 门手术 (MIMVS) 治疗严重的 mitra 门病理.
重制MIMVS,特别是冠状动脉后旁路移植 (CABG),对大动脉紧和心脏的传递提出了挑战.
在这些复杂的病例中,低温心室动被探索为替代心脏保护方法.

研究的目的:

在重复MIMVS中,评估低温心室的结果与常规前级心肌相比.
评估这种替代性心脏保护技术在患有重大并发症的患者中的安全性和有效性.

主要方法:

对48名患有低温心室的重复MIMVS (研究组) 患者的回顾性分析,与840名接受前期心肌的患者 (对照组) 相比.
从2011年1月到2022年12月收集的数据.
术后30天的观察期,分析中风,心肌梗塞,再手术和死亡率的发生率.

主要成果:

研究小组在手术前患有较高的功能衰竭,心脏外动脉病变,糖尿病和慢性肺病的患病率.
较长的手术时间和较低的 mitra 门修复率在低温心室动组中观察到.
两组之间没有发现30天死亡率,中风,心肌梗塞,额头膜再手术或术后膜功能障碍的显著差异.

结论:

低温心房动是一种安全有效的心脏保护策略,用于复杂并发症患者重复MIMVS.
这种技术显示了与常规心脏保护相匹配的安全性,但不增加不良事件.
低温心房动是挑战重复MIMVS程序的一个有希望的替代方案.

关键词:

低温心室纤维化低温心室纤维化结果就是结果.重新进行微创性 mitra 门手术.

更多相关视频

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

相关概念视频

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...